| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 |
| Profit before tax | -0.3 | -0.5 |
| Net income | -0.3 | -0.5 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC, OTC: AIBT. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Aibotics, Inc.: key numbers
- Share price
- $0.0029Close, Nov 20
- Market cap
- $2.9M
- Shares outstanding
- 1BLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Medicinal Chemicals & Botanical ProductsSIC 2833
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Aibotics, Inc.
All →Aibotics M&A Deal with PlayJamaica Limited
Aibotics, Inc. entered into a definitive agreement to acquire the robotics, drone services, AI, and mapping assets of PlayJamaica Limited for an initial consideration of $225,000 in Series B Preferred Stock. The deal includes an earn-out provision where PlayJamaica can receive up to an additional $3 million in preferred stock based on achieving $5 million in cumulative revenue over four years. Aibotics also committed to deploying $1 million in capital into the newly formed NovaCore Labs subsidiary over the next 12 months.
- Counterparty
- PlayJamaica Limited
Aibotics Signs $22M M&A Deal with Empulser Enterprises LLC
Aibotics Inc. has entered into a definitive agreement to acquire 100% of Empulser Enterprises LLC in exchange for Series C Preferred Stock with an aggregate stated value of up to $22 million. The deal includes an earn-out structure where 90% of the consideration is tied to ten specific milestones over a 36-month period, including patent filings, flight testing, and revenue targets. Upon closing, Empulser will become a wholly owned subsidiary of Aibotics.
- Value
- $22M
- Counterparty
- Empulser Enterprises LLC
- Term
- 36 months